Generation of gene-target dogs using CRISPR/Cas9 system
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
These authors contributed equally to this work. These authors contributed equally to this work. These authors contributed equally to this work. These authors contributed equally to this work. Dear Editor, Dogs (Canis familiaris) serve as human companions and are raised to herd livestock, aid hunters, guard homes, perform police and rescue work, and guide the blind. Dogs exhibit close similarities to humans in terms of metabolic, physiological, and anatomical characteristics, and thus are ideal genetic and clinical models to study human diseases (Tsai et al., 2007). Gene target technology is a powerful tool to create new strains of animals with favorable traits. However, thus far, gene-target dogs have not been developed due to their unique species-specific reproductive characteristics, which limits the applications of dogs especially in the field of biomedical research. Recently, clustered regularly interspaced short palindromic repeats (CRISPRs)/CRISPR-associated (Cas) 9 system was applied to edit specific genes with a high efficiency (Cong et al., 2013; Mali et al., 2013). Here we attempt to explore the feasibility of producing gene knockout (KO) dogs by using this technology. Beagle dog, the most widely used breed in biomedical research, was used as our animal model. Myostatin (MSTN) was chosen as the first gene of interest. MSTN is a negative regulator of skeletal muscle mass (McPherron et al., 1997). Spontaneous mutations of MSTN cause muscle hypertrophy in many species, including dogs (Mosher et al., 2007), without causing severe adverse consequences. We designed sgRNA targeting the first exon of the dog MSTN gene (Figure 1A). The efficiency of sgRNA was validated by co-transfection with Cas9 vector into canine embryonic fibroblasts (CEFs). Twenty-two colonies were harvested and lysed to test site-specific gene modification by polymerase chain reaction (PCR) amplification. The PCR products were used for T7 endonuclease I (T7E1) cleavage assay. Cleavage bands were found in seven colonies (Figure 1B). Further sequencing showed that 13 colonies (59.1%) were mutated at the cleaved site with various mutation sizes (from −13 to +1; Figure 1C). Among them, five colonies (22.7%) showed monoallelic mutation. There are eight colonies (36.4%) showing biallelic mutation, in which six colonies had the same mutation in both alleles (homozygous mutation) and two colonies displayed different mutation in each allele (Supplementary Figure S1). There are short repeats (GT, ATGT) around the sgRNA target locus, which probably cause microhomology-mediated end joining contributing to the high homogenous mutation rate (Morton et al., 2006; Qi et al., 2013). The other nine colonies (40.9%) were detected without mutations. These data demonstrated that our sgRNA functioned effectively in canine cells. Generation of MSTN mutant dogs by Cas9/sgRNA. (A) Schematic of sgRNA target site within exon 1 of dog MSTN locus. The sgRNA target site and PAM sequence are highlighted in gray. (B) Detection of sgRNA/Cas9-mediated cleavage of dog MSTN in CEF colonies by T7E1 cleavage assay. Samples with cleavage bands were marked with an asterisk (*). (C) Sequences of modified MSTN locus detected in CEF colonies. Target sequences are shown in boldface; PAM sequence is “TGG”, mutations in gray; ‘C’ stands for clone; ‘Δ’ stands for deletions; ‘+’ stands for insertions. (D) Summary of embryo microinjection of Cas9 mRNA and MSTN sgRNA in beagle dogs. (E) Sequencing of target site in both puppies #5 and #11. Puppy #5 had 8 bp deleted in one allele and was inserted with 1 bp in the other. Puppy #11 was deleted with 4 bp in both alleles. (F) DNA sequencing diagram and amino acid sequences of MSTN proximal to target site. Sequencing traits of nonsense mutations detected in both puppies #5 and #11. ‘---’ indicates stop codon sites. (G) Immunohistochemical analysis of MSTN protein expression in skeletal muscle of puppies #5 and #11 (light gray) and wild-type puppies #12 and #4 (dark gray). Scale bar, 50 μm. (H) Western blot showing the levels of MSTN precursor, C-dimer, and monomer in skeletal muscles of puppies #5 and #11 and wild-type puppies. β-actin was used as internal control. (I) The coronal T1-weighed images of the dog thighs. The sections were crossed the thighbone. The #5 and #11 are MSTN mutant puppies, and #4 and #12 are wild-type puppies. Scale bar, 2 cm. We next sought to generate MSTN KO dogs by manipulating dog zygotes. In initial trials, allo-transplantation of embryos was performed. A total of 30 presumptive zygotes were collected. Twenty-five embryos with normal morphology were immediately microinjected with a mixture of Cas9 mRNA and MSTN sgRNA. The injected embryos were transferred into six surrogate mothers with estrus that were presumptively synchronous with zygote donors. Unfortunately, none of the recipient mothers were found pregnant (Figure 1D). Compared with other mammals, dogs have several unique species-specific reproductive c
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1997) · Nature · doi:10.1038/387083a0 · Cited by 4,013
Mosher, D. S., Quignon, P., Bustamante, C. D., Sutter, N. B., Mellersh, C. S., Parker, H. G., & Ostrander, E. A. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030079 · Cited by 826 · cited 1×
“Spontaneous mutations of MSTN causes muscle hypertrophy in many species, including dogs (Mosher et al., 2007), without causing severe adverse consequences.”
Background
Cited by
Cornerstones of CRISPR–Cas in drug discovery and therapy
Fellmann, C., Gowen, B. G., Lin, P.-C., Doudna, J. A., & Corn, J. E. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.238 · Cited by 443
Xu, Y., & Li, Z. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.08.031 · Cited by 404
vonHoldt, B. M., Shuldiner, E., Koch, I. J., Kartzinel, R. Y., Hogan, A., Brubaker, L., Wanser, S., Stahler, D., Wynne, C. D. L., Ostrander, E. A., et al. (2017) · Science Advances · doi:10.1126/sciadv.1700398 · Cited by 186
The Ethics of Germline Gene Editing
Gyngell, C., Douglas, T., & Savulescu, J. (2017) · Journal of Applied Philosophy · doi:10.1111/japp.12249 · Cited by 174
The myostatin gene: an overview of mechanisms of action and its relevance to livestock animals
Aiello, D., Patel, K., & Lasagna, E. (2018) · Animal Genetics · doi:10.1111/age.12696 · Cited by 162
Metadata
- Authors
- Zou, Q., Wang, X., Liu, Y., Ouyang, Z., Long, H., Wei, S., Xin, J., Zhao, B., Lai, S., Shen, J., Ni, Q., Yang, H., Zhong, H., Li, L., Hu, M., Zhang, Q., Zhou, Z., He, J., Yan, Q., Fan, N., Zhao, Y., Liu, Z., Guo, L., Huang, J., Zhang, G., Ying, J., Lai, L., & Gao, X.
- Venue
- Journal of Molecular Cell Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-10-12
- Volume
- 7
- Issue
- 6
- Pages
- 580-583
- ISSN
- 1674-2788 (ISSN-L)
- 1759-4685
- OpenAlex
- W2172839874
- Cited by
- 132
- References
- 2
- FWCI
- 6.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.